Pasadena, CA, United States of America

Mackenzie Marrs

This inventor holds 1 USPTO granted patent. Top assignee: S&b Pharma, Inc.. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mackenzie Marrs. Retrieved from https://idiyas.com/inventor/mackenzie-marrs

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mackenzie Marrs: Innovator in Cannabidivarin Research

Introduction

Mackenzie Marrs is a notable inventor based in Pasadena, California. She has made significant contributions to the field of cannabinoid research, particularly focusing on cannabidivarin.

Latest Patents

Mackenzie holds a patent for "Crystalline cannabidivarin," which includes solid cannabidivarin, crystalline cannabidivarin, and various pure forms thereof. The patent also discloses methods for producing such compounds, as well as compositions and formulations that incorporate cannabidivarin. Furthermore, it outlines methods for treating diseases using this innovative compound.

Career Highlights

Mackenzie is currently employed at S&B Pharma, Inc., where she continues her research and development in cannabinoid applications. Her work is pivotal in advancing the understanding and utilization of cannabidivarin in medical treatments.

Collaborations

Mackenzie collaborates with esteemed colleagues, including Daniel A. Dickman and Emerich Eisenreich, who contribute to her research endeavors.

Conclusion

Mackenzie Marrs is a pioneering inventor whose work in cannabidivarin research is shaping the future of cannabinoid therapies. Her contributions are essential in the ongoing exploration of medical applications for cannabinoids.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…